US Market Access Strategy and Effort Prioritization

A US Pricing and Market Access team of a large pharma company needed to define collective priorities, ensure team and brand objectives, strategies and tactics are aligned to identified priorities, and establish an operational process to enable execution.

To start, our team gathered input from teams across the organization to understand the situation and needs. We developed a consolidated assessment including key access issues, organizational capabilities and gaps, and draft access objectives for each brand and customer/channel. We also developed a framework to define brand and above-brand priorities. Via working sessions with the market access leadership team, we defined collective priorities across and above brands while also ensuring cross-functional alignment. Working with the core team, we established an operational plan including governance, processes, templates and tools to support execution, tracking and measurement. Finally, we provided ongoing support to ensure a sustainable transition to new strategic approaches.

As a result of our work, the team received a clearly defined set of priorities, brand and team level objectives, strategies, tactics and resources aligned to those priorities, and an operational process to enable execution and tracking of progress.